Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans
Top Cited Papers
- 15 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (14) , 1877-1883
- https://doi.org/10.1161/01.cir.0000061950.24940.88
Abstract
Background— Inducing both maximal and steady-state coronary hyperemia is of clinical importance to take full advantage of fractional flow reserve measurements. The present study compares different dosages and routes of administration of adenosine 5′-triphosphate (ATP), adenosine, contrast medium, and papaverine regarding their potential to achieve both maximal and steady-state hyperemia.Keywords
This publication has 8 references indexed in Scilit:
- Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but “Normal” Coronary AngiographyCirculation, 2001
- Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserveAmerican Heart Journal, 1998
- Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserveCatheterization and Cardiovascular Diagnosis, 1996
- Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery diseaseJournal of the American College of Cardiology, 1995
- Intracoronary adenosine 5′-triphosphate as an alternative to papaverine for measuring coronary how reserveThe American Journal of Cardiology, 1994
- Coronary flow reserve in patients with chest pain and normal coronary arteries.Heart, 1993
- Intravenous adenosine: Continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery diseaseJournal of the American College of Cardiology, 1991
- Physiologic basis for assessing critical coronary stenosisThe American Journal of Cardiology, 1974